Wodicka conducts a collaborative research program in the area of biomedical acoustics - the application of sonic technologies toward the solution of problems in clinical medicine and pediatrics.  His current efforts include the design of acoustic guidance systems for neonatal catheters and tubes, the development of acoustic biosensors to monitor and quantify airway obstruction, and computational modeling and analysis of speech production in both health and disease. 

He co-founded with his graduate students SonarMed, Inc. which developed the only FDA-approved endotracheal tube monitoring system for advanced neonatal intensive care and was acquired by Medtronic, Inc. He currently advises and guides numerous collaborative investigations via his Indiana CTSI and Crossroads Pediatric Device Consortium leadership roles in order to expedite the translation of novel medical technologies into widespread clinical practice at scale.